Myriad Genetics (MYGN)
24.17
-0.15 -0.62%
NASDAQ
Jul 21, 16:59
Delayed 2m
USD
View All Key Stats
MYGN Key Stats
| Income Statement | |
| Revenue (TTM) | 757.30M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.45 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 32.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 77.50% |
| Profit Margin (Quarterly) | 2.13% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 1.646B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.229 |
| PE Ratio (TTM) | 53.71 |
| Price to Book Value | 2.201 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.2233 |
| Free Cash Flow (Quarterly) | 39.60M |
| Return on Equity (TTM) | 4.31% |
View All MYGN News
MYGN News
-
WireHeadlineTime (ET)
-
Yahoo07/21 20:20
-
Yahoo07/21 17:39
-
Yahoo07/10 15:31
-
Yahoo07/10 15:11
-
Yahoo06/29 15:06
-
Yahoo06/22 08:15
-
MT Newswires06/21 11:58
-
SA Breaking News06/21 09:16
-
Globe Newswire06/19 07:05
-
Yahoo06/19 07:05
View All Events
MYGN Events
| Date | Type | Description |
|---|---|---|
| 06/02/2017 | Misc | 53rd Annual Meeting of ASCO |
| 05/02/2017 16:30 EDT | Misc | Myriad Genetics Inc Third Quarter Earnings Conference Call in 2017 |
| 05/02/2017 | Earnings | Myriad Genetics Inc Third Quarter Earnings in 2017 Release |
| 02/07/2017 16:30 EST | Misc | Myriad Genetics Inc Second Quarter Earnings Conference Call in 2017 |
| 02/07/2017 | Earnings | Myriad Genetics Inc Second Quarter Earnings in 2017 Release |
| 12/01/2016 | Misc | Myriad Genetics Inc Annual General Meeting in 2016 |
| 11/01/2016 16:30 EDT | Misc | Myriad Genetics Inc First Quarter Earnings Results in 2017 |
| 11/01/2016 | Earnings | Myriad Genetics Inc First Quarter Earnings Results in 2017 Release |
| 09/01/2016 | Misc | Myriad Genetics Completes Acquisition of Assurex Health |
| 08/09/2016 16:30 EDT | Misc | Myriad Genetics Inc Fourth Quarter Earnings Conference Call in 2016 |
MYGN Fundamentals
Income Statement View Statement
MYGN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MYGN One Page Reports
- One Page Report Download
MYGN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 24.17 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.myriad.com
- Investor Relations URL: https://myriad.com/news-center/investor-information/
- HQ State/Province: Utah
- Sector: Healthcare
- Industry: Diagnostics & Research
- Next Earnings Release: N/A
- Last Earnings Release: May. 02, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
MYGN Comparables
EditMYGN Excel Add-In Codes
- Name: =YCI("MYGN","name")
- Description: =YCI("MYGN","description")
- Sector: =YCI("MYGN","sector")
- Industry: =YCI("MYGN","industry")
- Est. Current Fiscal Year End: =YCI("MYGN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MYGN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MYGN Tweets Stocktwits
Advertisement
